Norma Icon-5 & Norma Icon-5 OP hematology analyzers by NORMA INSTRUMENTS: Norma Instruments has introduced a new parameter in its Icon-5 and Icon-5 OP hematology analyzers, the NLR (Neutrophil-to-Lymphocyte Ratio). NLR was found to be the most significant factor affecting the severe illness incidence of patients who were diagnosed positive for COVID-19. These studies concluded that the age of the patient and the NLR value can be an early indication of the severity progress of the disease. Norma's Point-of-Care hematology analyzers with the new NLR parameter can be an excellent tool to help doctors at the frontline of the epidemic as CBC results can be obtained at the site resulting in quicker diagnosis helping patients to receive treatment faster. Faster treatment leads to faster emission or transfer time, thus helping to provide more efficient patient care.
- Healthcare
NORMA INSTRUMENTS is a Hungarian company that specializes in the designing and manufacturing of high quality and innovative blood analysis systems serving the in-vitro diagnostic (IVD) market. It was among the first companies to utilize microfluidic technologies in the development of hematology analyzers, which allowed them to develop the smallest hematology analyzers with the smallest sample volume processing and smallest reagent consumption in the world. NORMA INSTRUMENTS operates in nearly 70 countries through a well-established and well-trained distributing network. It has acquired several patents and awards, from which the most outstanding were the International Red Dot Design Award in 2014, the Hungarian Millennium Innovation Award in 2016 and the Hungarian Environmental Innovation Prize in 2018.